Physician profile
Heakyung Kim
NPI 1316960560
$52,672.54
in general payments reported to CMS, 2019-2025
10 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,086 · 2020: $2,957 · 2021: $5,800 · 2022: $4,688 · 2023: $566 · 2024: $10K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $18K · Consulting Fee: $7,695 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,050 · Food and Beverage: $1,330 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $17,982.92 |
| Consulting Fee | $7,695.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,050.00 |
| Food and Beverage | $1,329.81 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chugai Pharmaceutical Co., Ltd. | $18,897.60 | 2025 | |
| Merz Pharmaceuticals, LLC | $14,859.89 | 2021-2025 | Xeomin |
| Allergan, INC. | $10,160.16 | 2019-2022 | |
| Abbvie INC. | $4,518.38 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $2,741.19 | 2022-2025 | Iovera |
| Ipsen Biopharmaceuticals, INC | $1,427.71 | 2019-2025 | Dysport |
| Merz North America, INC. | $51.65 | 2019 | |
| Tersera Therapeutics LLC | $15.96 | 2023 | Prialt |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heakyung Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.